Voya Investment Management LLC Mei Pharma, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $20,861 - $32,285	-49,670 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $2,751 - $13,963	5,096 Added 11.43%	49,670 $30,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $8,057 - $11,653	-3,458 Reduced 7.2%	44,574 $119,000
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $10,636 - $14,932	-4,091 Reduced 7.85%	48,032 $137,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $11,195 - $18,454	4,101 Added 8.54%	52,123 $179,000
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $29,507 - $37,678	11,349 Added 30.95%	48,022 $127,000
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $13,638 - $40,445	-9,406 Reduced 20.41%	36,673 $151,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $5,546 - $18,857	7,395 Added 19.12%	46,079 $74,000
Q4 2019 Feb 14, 2020	BUY	$1.65 - $2.48 $21,431 - $32,212	12,989 Added 50.55%	38,684 $96,000
Q2 2019 Aug 14, 2019	BUY	$2.45 - $3.32 $62,952 - $85,307	25,695 New	25,695 $64,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.